Literature DB >> 9236730

Management of patients with depression associated with anxiety symptoms.

D Nutt1.   

Abstract

Current diagnostic classifications separate depression from anxiety, yet these conditions commonly coexist in clinical practice, forming a spectrum of disorders between these extremes. Treatment options for depression with anxiety include tricyclic antidepressants (TCAs) and serotonin selective reuptake inhibitors (SSRIs). As SSRIs are nonsedating, this proves that sedation as produced by TCAs is not required for anxiolytic actions. SSRIs are effective in anxiety disorders and against anxiety symptoms in depressed patients. The adverse event profile of SSRIs compares favorably with that of TCAs, and SSRIs are much safer in overdose. When the diagnosis of depression with anxiety is established, it is important to institute prompt, effective treatment in view of the potential risk of suicide. The SSRIs appear to be the treatment of choice for such patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236730

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.

Authors:  Isabella Helmreich; Stefanie Wagner; Roland Mergl; Antje-Kathrin Allgaier; Martin Hautzinger; Verena Henkel; Ulrich Hegerl; André Tadić
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-30       Impact factor: 5.270

2.  The development and initial validation of the Terminally Ill Grief or Depression Scale (TIGDS).

Authors:  Vyjeyanthi S Periyakoil; Helena C Kraemer; Art Noda; Rudolf Moos; James Hallenbeck; Maria Webster; Jerome A Yesavage
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

3.  Hemodynamic changes in depressive patients.

Authors:  Ying Ma; Hui-chun Li; Lei-lei Zheng; Hua-liang Yu
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

4.  Depressive comorbidity in children and adolescents with generalized anxiety disorder.

Authors:  G Masi; L Favilla; M Mucci; S Millepiedi
Journal:  Child Psychiatry Hum Dev       Date:  2000

5.  A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction.

Authors:  Robert L. Barkin; Philip N. Chor; Bennett G. Braun; William A. Schwer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-10

6.  Prevalence rate and influencing factors of preoperative anxiety and depression in gastric cancer patients in China: Preliminary study.

Authors:  Le Xu; Qiong Pan; Renqin Lin
Journal:  J Int Med Res       Date:  2016-02-08       Impact factor: 1.671

Review 7.  Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders.

Authors:  Yi Liu; Jingping Zhao; Wenbin Guo
Journal:  Front Psychol       Date:  2018-11-21

8.  Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder.

Authors:  Fenfen Ge; Jingwen Jiang; Yue Wang; Mentong Wan; Wei Zhang
Journal:  Front Psychiatry       Date:  2021-05-19       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.